CoChat

A Randomized, Double-Blind, Placebo-Controlled Trial of Olanzapine in the Treatment of Trichotillomania

Van Ameringen, Michael, Mancini, Catherine, Patterson, Beth, Bennett, Mark, Oakman, Jonathan · 2010 · The Journal of Clinical Psychiatry
Cited by 147

The DOI matches its Crossref record.

Abstract

Article AbstractBackground: Trichotillomania has been considered as part of the obsessive-compulsive disorder spectrum; however, trichotillomania treatment with obsessive-compulsive disorder medications has largely been unsuccessful. Objective: To determine whether a dopaminergic treatment as used in tics and Tourette's syndrome would be effective in trichotillomania. Method: Twenty-five participants with DSM-IV trichotillomania participated in a 12-week, randomized, double-blind, placebo-controlled trial of flexible-dose olanzapine for trichotillomania. Recruitment occurred between August 2001 and December 2005, and follow-up was completed in February 2006. The primary outcome measure was the Clinical Global Impressions-Improvement (CGI-I) scale, and secondary measures of efficacy included the Yale-Brown Obsessive Compulsive Scale for Trichotillomania (TTM-YBOCS) and the Clinical Global Impressions-Severity of Illness (CGI-S) scale. Results: Eleven of 13 participants (85%) in the olanzapine group and 2 of 12 (17%) in the placebo group were considered responders according to the CGI-I (P†‰=†‰.001). There was a significant change from baseline to end point in the TTM-YBOCS (P†‰<†‰.01) and the CGI-S (P†‰<†‰.001). The mean†‰±†‰SD dose of olanzapine at end point was 10.8†‰±†‰5.7 mg/d. Twenty-one of 25 patients (84%) reported at least 1 adverse event, but no adverse events resulted in early withdrawal from the study. Conclusion: Olanzapine seems to be a safe and effective treatment for primary DSM-IV trichotillomania. Trial Registration: clinicaltrials.gov Identifier: NCT00182507J Clin PsychiatrySubmitted: February 9, 2009; accepted May 15, 2009. Online ahead of print: April 20, 2010 (doi:10.4088/JCP.09m05114gre). Corresponding author: Michael Van Ameringen, MD, Anxiety Disorders Clinic, 1F Clinic, McMaster University Medical Centre, Hamilton Health Sciences, Box 2000, Hamilton, Ontario, L8N 3Z5, Canada (vanamer@mcmaster.ca).

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4088/jcp.09m05114gre

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 147

Metadata

Authors
Van Ameringen, M., Mancini, C., Patterson, B., Bennett, M., & Oakman, J.
Venue
The Journal of Clinical Psychiatry
Published
2010-04-20
Volume
71
Issue
10
Pages
1336-1343
ISSN
0160-6689 (ISSN-L)
OpenAlex
W2025562320
Cited by
147
References
0
FWCI
7.46
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A Randomized, Double-Blind, Placebo-Controlled Trial of Olanzapine in the Treatment of Trichotillomania. https://app.cochat.ai/papers/10.4088/jcp.09m05114gre
The paper
Van Ameringen, M., Mancini, C., Patterson, B., Bennett, M., & Oakman, J. (2010). A Randomized, Double-Blind, Placebo-Controlled Trial of Olanzapine in the Treatment of Trichotillomania. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.09m05114gre

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.